FDA goes on offense amid surge of criticism for recent drug decisions [CNN]
FDA goes on offense amid surge of criticism for recent drug decisions [CNN]
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines - QURE
Holzer & Holzer, LLC Reminds QURE Investors of the April 13, 2026 Lead Plaintiff Deadline in the uniQure N.V. Securities Class Action
FDA official calls UniQure's Huntington's disease treatment a failure [Yahoo! Finance]